La enfermedad de Parkinson es un trastorno neurodegenerativo complejo y de
presentación heterogénea. Aunque aún no se dispone de ningún fármaco que enlentezca …

Although levodopa remains the most effective drug for symptomatic management of
Parkinson's Disease (PD), treatment during advanced disease stages may raise …

Background Levodopa is the most effective therapy for Parkinson's disease, but chronic
treatment is associated with the development of potentially disabling motor complications …

Motor complications in Parkinson's disease (PD) are associated with long‐term oral
levodopa treatment and linked to pulsatile dopaminergic stimulation. l‐dopa‐carbidopa …

The deposition of alpha-synuclein in the brain, the neuropathological hallmark of
Parkinson's disease (PD), follows a distinct anatomical and temporal sequence. This study …

Background Peripheral neuropathy (PN) is common in patients with diseases that are in turn
associated with deficiency of the B‐vitamins, and vitamin treatment has shown mixed results …

The objectives of this study were to evaluate the risk of neuropathy in patients with
Parkinson's disease (PD) and to evaluate the role of levodopa exposure as a potential risk …

Background Clinical, neurophysiological, and pathological evidence suggest an association
between Parkinson's disease (PD) and peripheral neuropathy (PNP), with a possible …

ABSTRACT Background: In moderately advanced Parkinson's disease (PD), low serum
vitamin B12 levels are common and are associated with neuropathy and cognitive …

Neuropathies associated with nutritional deficiencies are routinely encountered by the
practicing neurologist. Although these neuropathies assume different patterns, most are …